← Back to Clinical Trials
Recruiting NCT06806774

NCT06806774 Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic Arthritis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06806774
Status Recruiting
Phase
Sponsor Hacettepe University
Condition Juvenile Idiopathic Arthritis (JIA)
Study Type OBSERVATIONAL
Enrollment 80 participants
Start Date 2025-04-10
Primary Completion 2026-10-31

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 18 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 80 participants in total. It began in 2025-04-10 with a primary completion date of 2026-10-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Juvenile Idiopathic Arthritis (JIA) is children's most common inflammatory rheumatic disease. The International League of Associations for Rheumatology (ILAR) defines it as a chronic arthritis condition that begins before the age of 16 lasts for six weeks or more, and has an unknown cause. Despite the gains made in the management of the disease of individuals with JIA with modern medical treatment methods, the physical and psychosocial problems caused by chronic inflammation negatively affect the daily living activities of individuals with JIA. On the other hand, in the JIA Core Set created by Outcome Measures in Rheumatology (OMERACT) in 2018, activities of daily living were included as a "mandatory area that should be evaluated in all studies." Therefore, to ensure that individuals with JIA reach a state of complete well-being, multi-interdisciplinary health professionals are expected to address the activities of daily living, identify the factors that limit these activities, and create intervention plans for the factors to be determined. The literature shows that the daily living activities of patients with JIA are addressed with a limited number of subjective measurement tools. However, these methods have disadvantages due to their subjectivity. In this case, objective measurement methods are needed to quantify the physical performance of patients with JIA in terms of their daily living activities. The Glittre Activities of Daily Living Test, initially developed by selecting activities similar to daily living activities to evaluate functional capacity in pulmonary diseases, has the potential to address this gap. Since the activities in the test require using both the lower and upper extremities, it has the advantage of reflecting functional capacity and providing information about performance in daily life activities. Although it has potential, the Glittre Activities of Daily Living Test needs appropriate psychometric properties for clinical settings and research for JIA patients. To our knowledge, no studies have been conducted in the current literature on the validity and reliability of the Glittre Activities of Daily Living Test in JIA patients. Therefore, this study aimed to evaluate the test-retest reliability, construct validity, and minimum detectable change of the Glittre Activities of Daily Living Test in assessing activities of daily living in children and adolescents with JIA.

Eligibility Criteria

Inclusion Criteria: * Being diagnosed with Juvenile Idiopathic Arthritis (JIA) according to The International League of Associations for Rheumatology (ILAR) classification * Being between the ages of 8-18 * Volunteering to participate in research Exclusion Criteria: * Advanced heart/lung/liver/kidney disease, neurological disease and malignancies * Having undergone major orthopedic surgery * Not volunteering to participate in the study

Contact & Investigator

Central Contact

Sinan Buran, MSc

✉ pt.sinanburan@gmail.com

📞 +905076393104

Principal Investigator

Sinan Buran, MSc

PRINCIPAL INVESTIGATOR

Hacettepe University Faculty of Physical Therapy and Rehabilitation

Frequently Asked Questions

Who can join the NCT06806774 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 18 Years, studying Juvenile Idiopathic Arthritis (JIA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06806774 currently recruiting?

Yes, NCT06806774 is actively recruiting participants. Contact the research team at pt.sinanburan@gmail.com for enrollment information.

Where is the NCT06806774 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye), Ankara, Turkey (Türkiye).

Who is sponsoring the NCT06806774 clinical trial?

NCT06806774 is sponsored by Hacettepe University. The principal investigator is Sinan Buran, MSc at Hacettepe University Faculty of Physical Therapy and Rehabilitation. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology